Latest Leverage News

EMVision Medical Devices is set to activate its sixth and final pivotal trial site at UCLA Health, advancing its emu™ brain scanner towards FDA submission. Meanwhile, the Continuous Innovation Study grows with the addition of Box Hill Hospital.

Chrysos Corporation reported a robust FY25 with 46% revenue growth and an 80% jump in EBITDA, driven by expanding adoption of its PhotonAssay technology and a landmark contract with gold giant Newmont. The company projects further growth in FY26 with revenue guidance of $80-90 million.

Omega Oil and Gas confirms the commercial viability of its Canyon Sandstone reservoir in Queensland’s Taroom Trough, with SLB modelling indicating nearly 1 million barrels of oil equivalent per well and significant upside potential.

Propel Funeral Partners has reported record FY25 results, exceeding revenue and EBITDA guidance while maintaining steady dividends and announcing a key executive transition.

Propel Funeral Partners reported a 7.9% revenue increase in FY25, driven by acquisitions and modest organic growth, while maintaining strong cash flow and a solid balance sheet. The company signals continued expansion supported by favorable demographics and a leadership transition.

Scentre Group reports a 3.2% rise in first-half Funds From Operations to $587 million and upgrades its full-year distribution guidance, reflecting strong retail property performance and strategic growth initiatives.

Prime Financial Group delivered a robust FY25 performance, with revenue climbing 21% and Funds Under Management soaring 58% following a key acquisition. The company sets sights on doubling revenue within five years.

Prime Financial Group Ltd has reported a robust 21% increase in revenue to $49.4 million for FY25, alongside a 62% jump in net profit after tax. The company’s strategic acquisition of Lincoln Indicators Pty Ltd bolsters its wealth management capabilities and client base.

Austco Healthcare has reported a robust FY25 with revenues climbing 40% to $81.4 million and EBITDA jumping 62% to $13 million, driven by organic growth and strategic acquisitions.

Austco Healthcare Limited reported a record $81.4 million in revenue for FY25, driven by organic growth and acquisitions including G&S Technologies. EBITDA jumped 62% to $13 million, reflecting strong operational leverage.

Kelsian Group reported a strong FY25 with revenue up 9.5% and EBITDA growth of 7.4%, underpinned by contract renewals and operational excellence. The company also advanced key strategic initiatives including a Tourism Portfolio sale and UK expansion.

Beforepay Group Limited reported a strong FY25 with a 29% increase in net transaction margin and 14% revenue growth, driven by expanding user numbers and advances. The company continues to leverage AI-driven risk management while maintaining its ethical lending model.